Short Interest in Aptorum Group Limited (NASDAQ:APM) Rises By 1,564.9%

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 184,800 shares, an increase of 1,564.9% from the December 31st total of 11,100 shares. Approximately 4.7% of the company’s stock are sold short. Based on an average daily volume of 2,190,000 shares, the short-interest ratio is currently 0.1 days.

Aptorum Group Stock Performance

Shares of NASDAQ APM opened at $1.10 on Wednesday. Aptorum Group has a one year low of $0.46 and a one year high of $17.49. The business’s 50-day moving average price is $1.09 and its two-hundred day moving average price is $1.96.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.